Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Laboratorio Chimico Deca is an Italian pharmaceutical company based in Bologna, specializing in the development and commercialization of therapeutic solutions for the respiratory system and ear, nose, and throat (ENT) health. Founded in 1947, the company offers a diverse portfolio that includes prescription medicines, medical devices, and food supplements. Its flagship products, such as Rinostil and Otostil, are widely recognized in the Italian market for treating conditions like rhinitis and otitis. Deca maintains a strong focus on pediatric and adult care, providing effective treatments for common ailments of the upper and lower respiratory tracts through various delivery forms including aerosols, drops, and syrups.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Laboratorio Chimico Deca.